ResMed Inc. vs Suncor Energy Inc. — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.89B), while Suncor Energy Inc. trades at $69.02 (market cap $79.39B). The key difference: Suncor Energy Inc. is far larger — about 2.5× ResMed Inc.'s market cap, and Suncor Energy Inc. pays the higher dividend (2.55%). Which is the better fit depends on your goals.
| RMD | SU | |
|---|---|---|
Market Cap | $31.89B | $79.39B |
Sector | Health | Energy |
52-Week High | $283.28 | $69.73 |
52-Week Low | $182.82 | $38.17 |
Enterprise Value | $31.24B | $86.13B |
Dividend Yield | 1.19% | 2.55% |
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support at $218. The company reported strong Q4 2026 results with EPS of $2.95 beating estimates, and revenue grew 9% to a record $1.5 billion. However, weaker fiscal 2027 revenue guidance has pressured the stock. Fundamentals remain solid with a 26.94% net income margin and robust cash flow from operations of $1.75 billion in 2025.
The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.70 consensus price target, but near-term sentiment is cautious due to the soft sales forecast and ongoing legal investigations. Key risks include competitive pressures and execution on guidance. Institutional buying by firms like HSBC and Canada Pension Plan provides confidence in long-term value.
Suncor Energy (SU) trades at $67.89, up 0.83% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 12.54 and net income margin of 14.7%, supported by Q2 2026 earnings beating estimates. Recent news highlights leadership transition to Peter Zebedee as CEO in 2027 and a dividend declaration of $0.60 per share payable September 25, 2026.
Outlook remains positive due to robust cash flow and buyback increases, but risks include commodity price volatility and operational challenges from weather events. Analyst consensus is strongly bullish with 74% buy ratings, indicating confidence in sustained performance amid energy market fluctuations.
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →